Calciferol
Overview
Leflunomide is used for its immunosuppressant properties, in the treatment of moderate to severe active rheumatoid arthritis and in active psoriatic arthritis. The immunosuppressant properties are partly due to the action of its active metabolite A77-1726 in inhibiting pyrimidine synthesis. Leflunomide is under invastiagation for its use in organ and tissue transplantation.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Calciferol's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 1 ug/ kg | 1 (1) | 24 hourly | PO | |
| 1.4 ug/ kg | 1.4 (1.4) | 24 hourly | PO | |
Paedriatic Dosage (20kg)
|
| 150 IU/kg | 150 (150) | 24 hourly | Oral | For Treatment |
Neonatal Dosage (3kg)
|
| 187.5 units/kg | 190 (187.5) | 24 hourly | oral | |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Calciferol
Back to top
Previous Drug Generic - Next Drug Generic